and Holmgren, A., Free
Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin 21 in mice
supports insulin sensitivity Nervous System: Protects against neurodegeneration and cognitive decline Skin: Improves autoimmune conditions and accelerates wound healing Future Applications of GLP-1 Medications As clinical trials continue, GLP-1 receptor agonists may soon be approved for: Neurodegenerative diseases: Alzheimers, Parkinsons, MS Autoimmune conditions: Psoriasis, RA, Lupus Cardiometabolic syndromes: NAFLD, PCOS, atherosclerosis Pulmonary conditions: Chronic bronchitis, COPD, even long-COVID inflammation Final Thoughts GLP-1 medications are no longer just diabetes or weight loss drugs
Inborn defects in the antioxidant systems of human red blood cells
Tirzepatide is also the active ingredient in Mounjaro, which is approved for type 2 diabetes
Similar findings were observed with sestrin2 downregulation (Qian et al., 2023)